GHZ Partners | IT Services, Software

McKesson Playing Pivotal Role in Phase II of Friends of Cancer Research Real-World Evidence Initiative

IRVING, Texas, August 8, 2019—McKesson is pleased to announce that it is participating in Phase II of the Friends of […]

TURALIO (pexidartinib), FDA Approved Treatment of TGCT, Available at Biologics by McKesson

CARY, N.C. (August 7, 2019) — Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, […]

NUBEQA (darolutamide), FDA Approved for Treatment of High-Risk Non-Metastatic Prostate Cancer, Available at Biologics by McKesson

CARY, N.C., August 1, 2019—Biologics by McKesson, an independent specialty pharmacy for oncology and other complex therapeutic areas, was selected […]

McKesson Reports Fiscal 2020 First-Quarter Results

First-quarter fiscal 2020 revenues of $55.7 billion, an increase of 6%.First-quarter GAAP earnings per diluted share from continuing operations of […]

McKesson Opens New Distribution Center in Seattle Area

PUYALLUP, Wash., July 25, 2019 — McKesson Corporation has opened a new distribution center in Puyallup, Washington – 35 miles […]

McKesson Named One of the Best Places to Work for Disability Inclusion

For the fourth year in a row, McKesson was named a ‘Best Place to Work’ for Disability Inclusion. McKesson earned […]

Northern California Prostate Cancer Center Joins The US Oncology Network, Advancing Quality Care and Operational Efficiency

CAMPBELL, Calif. (July 9, 2019) — Northern California Prostate Cancer Center (NCPCC), an independent oncology practice serving cancer patients throughout […]

News Categories